Who is Rapid And Success? The Comparison Of Video Fiberscope And Video Laryngoscope
Launched by ONDOKUZ MAYIS UNIVERSITY · Feb 7, 2022
Trial Information
Current as of September 29, 2025
Completed
Keywords
ClinConnect Summary
In this randomized and prospective study, 60 patients with EGRI score\> 4 and ASA score \<4, operated between 1 October 2018 and 1 March 2019 in Ondokuz Mayıs University Medical Faculty Hospital were included. Endotracheal intubation was performed by two practitioners using two different devices. Intubation times, number of attempts, failed attempts, postoperative complications and hemodynamic responses were recorded.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Operated in the operating room of our hospital,
- • Aged 18-65,
- • EGRI score\>4,
- • ASA (American Society of Anesthesiologists) score\<4
- Exclusion Criteria:
- • Cerebrovascular disease (cerebral ischemia, hemorrhage or stroke), presence of carotid stenosis or history of coronary artery disease,
- • Neurological disorders (history of chronic headache, epilepsy or head trauma), alcohol or psychoactive drug addiction,
- • Serious heart and/or lung diseases, liver and/or kidney failure,
- • Uncontrolled diabetes and/or hypertension,
- • Dental abscess,
- • Mouth opening \<1.5 cm,
- • Known bleeding disorder,
- • Pregnancy,
- • Mental retardation,
- • Contraindications to drugs, allergy to drugs used,
- • Patient rejection
About Ondokuz Mayıs University
Ondokuz Mayıs University is a prestigious academic institution located in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its cutting-edge facilities and a multidisciplinary team of experts to conduct innovative studies that aim to enhance patient care and contribute to scientific knowledge. With a focus on ethical standards and rigorous methodologies, Ondokuz Mayıs University is dedicated to fostering collaborations that drive breakthroughs in healthcare, ultimately improving treatment outcomes and patient well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samsun, Atakum, Turkey
Patients applied
Trial Officials
ERSIN KOKSAL, PROFFOSOR
Study Director
Ondokuz Mayıs University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials